433 related articles for article (PubMed ID: 9247841)
1. Propylthiouracil-induced cutaneous vasculitis.
Yarman S; Sandalci O; Tanakol R; Azizlerli H; Oguz H; Alagöl F
Int J Clin Pharmacol Ther; 1997 Jul; 35(7):282-6. PubMed ID: 9247841
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
3. Leukocytoclastic vasculitis: a rare manifestation of propylthiouracil hypersensitivity.
Erem C; Yucel Y; Ya Z; Reis A; Kocak M; Hacihasanoglu A
Med Princ Pract; 2005; 14(5):366-9. PubMed ID: 16103706
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibody-positive cutaneous leukocytoclastic vasculitis associated with propylthiouracil therapy.
Sheen YS; Chu CY; Yu HS
Arch Dermatol; 2006 Jul; 142(7):879-80. PubMed ID: 16847204
[No Abstract] [Full Text] [Related]
6. Propylthiouracil-induced autoimmune syndromes: two distinct clinical presentations with different course and management.
Aloush V; Litinsky I; Caspi D; Elkayam O
Semin Arthritis Rheum; 2006 Aug; 36(1):4-9. PubMed ID: 16887463
[TBL] [Abstract][Full Text] [Related]
7. Recurrent episodes of arthritis in a hyperthyroid patient.
Tan F; Nam TQ; Lee KO; Cheah WK; Mukherjee JJ
Singapore Med J; 2006 Feb; 47(2):163-5. PubMed ID: 16435062
[TBL] [Abstract][Full Text] [Related]
8. Necrotizing vasculitis in a patient affected by autoimmune hyperthyroidism treated with propylthiouracil.
Antonucci A; Bardazzi F; Iozzo I; Patrizi A
Dermatol Ther; 2010; 23 Suppl 2():S41-3. PubMed ID: 20482568
[TBL] [Abstract][Full Text] [Related]
9. Propylthiouracil-induced hypersensitivity syndrome.
Aycan Z; Arhan E; Cetinkaya E; Vidinlisan S; Menekşe N; Yücel H; Cakar N
Turk J Pediatr; 2006; 48(2):162-5. PubMed ID: 16848120
[TBL] [Abstract][Full Text] [Related]
10. Cryoglobulins and multispecific antineutrophil cytoplasmic antibodies in propylthiouracil-induced necrotizing cutaneous vasculitis--a new association.
Zivanovic D; Dobrosavljevic D; Nikolic M; Bonaci-Nikolic B
Eur J Dermatol; 2012; 22(5):707-9. PubMed ID: 22858991
[No Abstract] [Full Text] [Related]
11. [Leukocytoclastic vasculitis as an adverse effect of propylthiouracil. A case report].
Cortés-Guzmán JS; Veloza KT; Domínguez JD; Pinzón-Tovar A
Rev Alerg Mex; 2023 May; 70(1):51-54. PubMed ID: 37566757
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibody associated vasculitis and rapidly progressive glomerulonephritis as a complication of propylthiouracil therapy.
Erten Y; Bodur H; Sahiner S; Tolunay O; Akkaya V; Canbakan B; Bali M
Clin Endocrinol (Oxf); 2002 Nov; 57(5):699-700. PubMed ID: 12390348
[No Abstract] [Full Text] [Related]
13. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
Kubota S
Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
[TBL] [Abstract][Full Text] [Related]
14. [Necrotizing vasculitis as a manifestation of hypersensitivity to propylthiouracil].
Dinato SL; Dinato MC; Dinato MM; Ribeiro MC; Yamashiro CY; Romiti N
Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):374-7. PubMed ID: 19578601
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves' disease.
Miller RM; Savige J; Nassis L; Cominos BI
Australas J Dermatol; 1998 May; 39(2):96-9. PubMed ID: 9611379
[TBL] [Abstract][Full Text] [Related]
16. Lichenoid drug eruption of nails induced by propylthiouracil.
Saito M; Nakamura K; Kaneko F
J Dermatol; 2007 Oct; 34(10):696-8. PubMed ID: 17908140
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous vasculitis associated with propylthiouracil therapy.
Carrasco MD; Riera C; Clotet B; Grifol M; Foz M
Arch Intern Med; 1987 Sep; 147(9):1677. PubMed ID: 3632175
[TBL] [Abstract][Full Text] [Related]
18. Henoch-Schönlein purpura associated with propylthiouracil overdose.
Lee JE; Jeon CH; Chang DK; Lee MS; Oh HY
Nephrol Dial Transplant; 2006 Aug; 21(8):2338-9. PubMed ID: 16554322
[No Abstract] [Full Text] [Related]
19. Propylthio-uracil-induced cutaneous vasculitis.
Gammeltoft M; Kristensen JK
Acta Derm Venereol; 1982; 62(2):171-3. PubMed ID: 6179348
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous leukocytoclastic vasculitis in the presence of methimazole therapy.
Ribeiro Cde O; Magrin PF; Vilar EA; Durães SM; Estrella RR
An Bras Dermatol; 2013; 88(2):283-6. PubMed ID: 23739718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
